2005 Life Sciences Industry Summit Convenes Nationally Renowned Keynotes

For Immediate Release Contact Angeline Judex (631) 632-8521

STONY BROOK, NY, Wed, Apr 6, 2005 — Key executives from New York’s life sciences industry will gather to address a series of critical issues at a summit meeting designed to explore and organize around topics of strategic importance to the Industry. The 2005 Life Sciences Industry Summit –Assets and Opportunities, to be held on Thursday, May 5th from 8 AM to 5:00 PM at the Hilton Huntington Hotel, is expected to attract 300 senior industry executives from throughout the tri-state region.

Highlights of the meeting will include an opening plenary on “Personalized Medicine: The Emerging Pharmacogenomics Revolution,” which will explore the impact of personalized medicine on established and emerging industry, government policy, and patients. The luncheon plenary will feature Richard Preston, Ph.D., the best-selling author of “The Demon in the Freezer,” “The Cobra Event” and “The Hot Zone” and leading authority on biological terrorism. Dr. Preston’s critically acclaimed books have proven his status as a first rate investigative journalist and gifted storyteller and put him in the forefront of the emerging diseases and biotechnology arenas. The 2005 Summit will close with a keynote address by Dr. Neil Gibson, Senior Vice President for Research, OSI Pharmaceuticals who will discuss the revolutionary direction that cancer therapeutics will take in the 21st century.

Attendees at the 2005 Summit will participate in a day long event with more than 50 distinguished speakers in spirited presentations and discussions covering topics in business development, financing, intellectual property, workforce development and public policy. Additional sessions will include the Investor Roundtable, Emerging Technology Showcase and Emerging Company Showcase.

Produced by the Long Island Life Sciences Initiative (LILSI) and the Center for Biotechnology at Stony Brook University, the 2005 Summit is the premier industry event for the broader life sciences industry. Industry leaders representing the pharmaceutical, biotechnology, medical device and life systems technology industries, along with leaders from the academic community, venture capitalists, professional service providers, and economic development professionals, will engage in a dynamic forum to discuss issues of strategic importance to the life sciences industry.

Complete Summit information can be obtained by contacting Joseph Scaduto, Executive Director, Long Island Life Sciences Initiative at (631) 632-1991, or by visiting www.lilsi.org.